Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 06, 2008 08:30 ET | Source: Delcath Systems, Inc.

Investigator Presents on Delcath Systems Phase III Trial Experience

NEW YORK, NY--(Marketwire - October 6, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) reported that the Adjunct Principal Investigator for its Phase III clinical trial, James Pingpank, Jr., MD,...
October 02, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Systems to Present at the Maxim Group Growth Conference

NEW YORK, NY--(Marketwire - October 2, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH), a leading developer of regional therapy for cancer, announced today that its management will present at the Maxim...
September 24, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Adds Providence Cancer Center to Phase III Trial

NEW YORK, NY--(Marketwire - September 24, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Robert W. Franz Cancer Research Center, a part of the Providence Cancer Center, located...
September 19, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Systems Targeted Drug Delivery Technology to Be Presented at Western Angiographic and Interventional Society Annual Meeting

NEW YORK, NY--(Marketwire - September 19, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH), a leading developer of regional therapy for cancer, today announced that Dr. Charles Nutting of Swedish...
September 02, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Cancer Trials Welcome New Principal Investigator From NCI

NEW YORK, NY--(Marketwire - September 2, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the National Cancer Institute (NCI) has named Dr. Marybeth S. Hughes, MD as the Principal...
August 28, 2008 14:44 ET | Source: Delcath Systems, Inc.

Delcath Systems to Host Quarterly Update Conference Call

NEW YORK, NY--(Marketwire - August 28, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Company will host a quarterly update conference call. Richard Taney, President and Chief...
August 21, 2008 08:00 ET | Source: Delcath Systems, Inc.

Delcath Expands Phase III Trial for Metastatic Melanoma to Include Swedish Medical Center in Colorado

NEW YORK, NY--(Marketwire - August 21, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Swedish Medical Center in Englewood, Colorado, has joined Delcath's Phase III clinical...
August 12, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Expands Phase III Trial for Metastatic Melanoma to Include John Wayne Cancer Institute in California

NEW YORK, NY--(Marketwire - August 12, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the John Wayne Cancer Institute ("JWCI"), at Saint John's Health Center in Santa Monica,...
August 07, 2008 14:24 ET | Source: Delcath Systems, Inc.

Delcath Systems to Present at the 28th Annual Canaccord Adams Global Growth Conference

NEW YORK, NY--(Marketwire - August 7, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) today announced that Richard L. Taney, President and CEO of Delcath Systems, Inc., will present at the 28th Annual...
July 24, 2008 08:30 ET | Source: Delcath Systems, Inc.

Delcath Expands Phase III Trial for Metastatic Melanoma to Florida

NEW YORK, NY--(Marketwire - July 24, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that Moffitt Cancer Center ("Moffitt"), a National Cancer Institute Comprehensive Cancer Center, has...